Trademark Overview
On Wednesday, January 14, 2026, a trademark application was filed for AZURECELL with the United States Patent and Trademark Office. The USPTO has given the AZURECELL trademark a serial number of 79448144. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, April 16, 2026. This trademark is owned by AZURECELL SA. The AZURECELL trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical services; regenerative medicine services; cultured cell bank services for medical transplantation; medical treatment services by means of cultured cells; medical treatment services by means of cell therapy; preparation, expansion and characterization of cells for therapeutic purposes; clinical advice on cell therapy; genetic analysis services for medical use.
Biological preparations other than for medical or veterinary use; stem cells other than for medical or veterinary use; non-stem cells other than for medical or veterinary use; cell culture reagents, matrices and media other than for medical or veterinary use; cell lines for scientific use; molecular genetics reagents, plasmids, and vectors for scientific use.
Scientific and technological services as well as research and design services relating thereto; scientific and technological services in the field of cell therapy; scientific and technological services in the field of genetic engineering; genetic engineering services; scientific and technological services in the field of brain and nervous system conditions; scientific and technological services in the field of neuroregenerative medicine and neurobiology; synthetic biology research and development; design, especially assisted by artificial intelligence, of therapeutic proteins; development and validation of production processes for cell therapy agents for quality or standards certification; design and development of tests to identify, quantify, analyze, and validate biomarkers in the field of brain or nervous system degeneration; bioinformatics-based medical data analysis services in the field of brain or nervous system degeneration.
Pharmaceutical products, medical and veterinary preparations; pharmaceutical preparations for activating cellular functions; medical preparations for the treatment of the brain and nervous system, including neurodegenerative diseases and movement disorders; medical preparations for the treatment of Parkinson's disease; biotechnological preparations for medical use; biotechnological preparations for gene or cell therapy; cells for medical use; living cells and living tissues for medical use; theranostic therapeutic cells; surgical implants consisting of living tissues and cells; chemical or biological reagents and culture media for medical use; diagnostic agents for medical use; diagnostic kits for medical use.
